- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 19.74M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 19.7M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 19.6M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $7.88M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $15.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $11.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $20.52M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $16.96M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $12.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.13M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $50.14M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $34.55M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $34.7M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.38M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.4M |